4baseCare raises ₹38 Cr to close its Series B round at ₹128 Cr, led by growX Ventures, to expand its genomics laboratory globally and scale its AI-driven precision oncology platform.
Healthtech startup 4baseCare has secured an additional ₹38 Cr to close its Series B round at ₹128 Cr, led by growX Ventures. The funds will be used to expand its genomics laboratory network globally and scale its AI-driven precision oncology platform, OncoTwin. This follows a previous raise of ₹90 Cr in the same round. The company aims to leverage advanced genomics, bioinformatics, and AI for personalized oncology care.
Company Information
Company
4baseCare
Location
Bengaluru, Karnataka, India
About
4baseCare is a Bengaluru-based startup that specializes in precision oncology solutions using advanced genomics and digital health technology. As an Illumina Accelerator company, it has made significant strides in impacting cancer care across Southeast Asia. The company aims to enhance genomic tests and make personalized cancer care accessible to millions. With a strong founding team and notable advisory board, 4baseCare is poised for growth and innovation in genomics.
Fundz sees it the moment 4baseCare raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BengaluruBiotechnologyHealth CareGeneticsHealth Diagnostics